Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-05 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0002 |